Chemotherapeutic resistance is a major obstacle to the effectiveness of cisplatin-based chemotherapy for gastric cancer (GC), leading to treatment failure and poor survival rates. However, the underlying mechanisms are not fully understood. Our study demonstrated that the transcription factor myocyte enhancer factor 2A (MEF2A) plays a role in chemotherapeutic drug resistance by regulating the transcription of PGC1α and KEAP1, promoting mitochondrial biogenesis. It was found that increased MEF2A expression is linked with poor prognosis, cisplatin insensitivity, and mitochondrial function in GC. MEF2A overexpression significantly decreases GC cell sensitivity in vitro and in vivo, while MEF2A knockdown enhances the sensitivity to cisplatin. Mechanistically, MEF2A activates the transcription of PGC1α, leading to increased mitochondrial biogenesis. In addition, MEF2A inhibits KEAP1 transcription, reduces NRF2 ubiquitination degradation, and activates the KEAP1/NRF2 signaling pathway, which modulates the reactive oxygen species level. The present study identifies MEF2A as a new critical oncogene involved in GC chemoresistance, suggesting a novel therapeutic target for GC.

UNASSIGNED: Limited epidemiological evidence suggests that exposure to trace elements adversely impacts the development of gastric precancerous lesions (GPL) and gastric cancer (GC). This study aimed to estimate the association of individual urinary exposure to multiple elements with GPL and GC.
UNASSIGNED: A case-control investigation was conducted in Anhui Province from March 2021 to December 2022. A total of 528 subjects (randomly sampled from 1,020 patients with GPL, 200 patients with GC, and 762 normal controls) were included in our study. Urinary levels of iron (Fe), copper (Cu), zinc (Zn), nickel (Ni), strontium (Sr), and Cesium (Cs) were measured using inductively coupled plasma mass spectrometry (ICP-MS). Four different statistical approaches were employed to explore the risk of GPL and GC with mixed exposure, including multivariate logistic regression, weighted quantile regression (WQS), quantile g-computation (Qgcomp), and the Bayesian kernel machine regression (BKMR) model.
UNASSIGNED: The WQS model indicated that urinary exposure to a mixture of elements is positively correlated with both GPL and GC, with ORs for the mixture exposure of 1.34 (95% CI: 1.34-1.61) for GPL and 1.38 (95% CI: 1.27-1.50) for GC. The Qgcomp and BKMR models also demonstrated a statistically significant positive correlation between the mixture and both GPL and GC.
UNASSIGNED: Considering the limitations of case-control studies, future prospective studies are warranted to elucidate the combined effects and mechanisms of trace elements exposure on human health.

Platelets (PLTs) facilitate tumor progression and the spread of metastasis. They also interact with cancer cells in various cancer types. Furthermore, PLTs form complexes with gastric cancer (GC) cells via direct contact and promote their malignant behaviors. The objective of the present study was to explore the molecular mechanisms driving these interactions and to evaluate the potential for preventing peritoneal dissemination by inhibiting PLT activation in GC cells. The present study examined the roles of PLT activation pathways in the increased malignancy of GC cells facilitated by PLT-cancer cells. Transforming growth factor-β receptor kinase inhibitor (TRKI), Src family kinase inhibitor (PP2) and Syk inhibitor (R406) were used to identify the molecules influencing these interactions. Their therapeutic effects were verified via cell experiments and validated using a mouse GC peritoneal dissemination model. Notably, only the PLT activation pathway-related inhibitors TRKI and PP2, but not R406, inhibited the PLT-enhanced migration and invasion of GC cells. In vivo analyses revealed that PLT-enhanced peritoneal dissemination was suppressed by PP2. Overall, the present study revealed the important role of the Srk family in the interactions between PLTs and GC cells, suggesting kinase inhibitors as promising therapeutic agents to mitigate the progression of peritoneal metastasis in patients with GC.

Atopic diseases, including atopic dermatitis (AD) and allergic asthma (AA), are characterized by complex immune responses involving various T cells subsets and their cytokine profiles. It is assumed that single nucleotide polymorphisms (SNPs) in the Vitamin D receptor (VDR) gene and the Vitamin D-binding protein (GC) gene are related to the action of Vitamin D and, consequently, play a role in regulating the immune response. However, there is not enough data to unequivocally support the hypothesis about the relationship between T cells profile and VDR or GC SNPs. Two hundred sixty-six subjects (aged > 18 years) were involved in the study: 100 patients with mild or moderate AD, 85 patients with mild or moderate AA, and 81 healthy individuals. Blood cell counts were determined by standard methods. Flow cytometric analysis was used to evaluate CD4+ T-helper (Th) cell subtypes: Th2, Th1, Th17, and T regulatory (Treg) cells in peripheral blood. Measurements of cytokines, total immunoglobulin E (IgE), and Vitamin D levels in serum were evaluated by ELISA. Significantly higher levels of Th1, Th2, and Th17 cells, along with lower levels of Tregs, were found in patients with atopic diseases compared to healthy individuals. Additionally, higher serum levels of interleukin (IL) 5, IL-17A, and transforming growth factor-β1 (TGF-β1), as well as lower levels of IL-10, were observed in patients with atopic diseases than in control. The study established associations between VDR SNPs and immune profiles: the AA genotype of rs731236 was associated with increased Th2 and Th17 cells and a higher Th1/Th2 ratio; the GG genotype of rs731236 was linked to decreased serum IL-10 and TGF-β1 levels; and the TT genotype of rs11168293 was associated with increased IL-10 levels. Additionally, the GG genotype of GC gene SNP rs4588 was associated with reduced Th2 and Th17 lymphocytes, while the TT genotype of rs4588 was linked to decreased IL-10 levels. Furthermore, the CC genotype of rs7041 was associated with higher levels of Th2, Th17, IL-10, and IL-35, as well as reduced levels of TGF-β1, while the GG genotype of rs3733359 was associated with reduced IL-10 levels. In conclusion, our study demonstrates that the Vitamin D receptor gene single nucleotide polymorphisms rs731236 and rs11168293, along with polymorphisms in the Vitamin D-binding protein gene (rs4588, rs7041, rs3733359), are significantly associated with variations in T cell profiles in atopy. These variations may play a crucial role in promoting inflammation and provide insight into the genetic factors contributing to the pathogenesis of atopy.

This paper introduces a method for determining the specific surface area (SSA) of biomass activated carbon (BAC) using a tracer-based headspace gas chromatography (HS-GC) technique. The method relies on the adsorption equilibrium of methanol on BAC samples at elevated temperature. A mathematical model allows for the calculation of SSA from the methanol signal obtained during the headspace analysis. The results demonstrate high precision (relative standard deviation < 2.44%) and strong accuracy (correlation with the conventional BET-N2 adsorption method, R² = 0.986). This method offers several advantages over traditional techniques, including ease of operation, significant time efficiency, and the the ability to perform batch determinations of SSA, as multiple samples can be processed simultaneously during the phase equilibrium step.

BACKGROUND: Gastric cancer (GC) is a prevalent malignant tumor, and the RNA-binding protein polypyrimidine tract-binding protein 1 (PTBP1) has been identified as a crucial factor in various tumor types. Moreover, abnormal autophagy levels have been shown to significantly impact tumorigenesis and progression. Despite this, the precise regulatory mechanism of PTBP1 in autophagy regulation in GC remains poorly understood.
METHODS: To assess the expression of PTBP1 in GC, we employed a comprehensive approach utilizing western blot, real-time quantitative polymerase chain reaction (RT-qPCR), and bioinformatics analysis. To further identify the downstream target genes that bind to PTBP1 in GC cells, we utilized RNA immunoprecipitation coupled with sequencing (si-PTBP1 RNA-seq). To evaluate the impact of PTBP1 on gastric carcinogenesis, we conducted CCK-8 assays, colony formation assays, and GC xenograft mouse model assays. Additionally, we utilized a transmission electron microscope, immunofluorescence, flow cytometry, western blot, RT-qPCR, and GC xenograft mouse model experiments to elucidate the specific mechanism underlying PTBP1\'s regulation of autophagy in GC.
RESULTS: Our findings indicated that PTBP1 was significantly overexpressed in GC tissues compared with adjacent normal tissues. Silencing PTBP1 resulted in abnormal accumulation of autophagosomes, thereby inhibiting GC cell viability both in vitro and in vivo. Mechanistically, interference with PTBP1 promoted the stability of thioredoxin-interacting protein (TXNIP) mRNA, leading to increased TXNIP-mediated oxidative stress. Consequently, this impaired lysosomal function, ultimately resulting in blockage of autophagic flux. Furthermore, our results suggested that interference with PTBP1 enhanced the antitumor effects of chloroquine, both in vitro and in vivo.
CONCLUSIONS: PTBP1 knockdown impairs GC progression by directly binding to TXNIP mRNA and promoting its expression. Based on these results, PTBP1 emerges as a promising therapeutic target for GC.

Proliferation is a critical characteristic of the progression of gastric cancer (GC). Receptor tyrosine kinase-like orphan receptor 2 (ROR2), the orphan receptor tyrosine kinase-like receptor, exhibits effects on tumor growth due to its abnormal expression in cancer. The goal of our study was to assess the potential regulatory role exerted by the ROR2 on GC cells. Through previous bioinformatics analysis, we discovered an association between ROR2 and the G2/M phase of the GC cell cycle. However, little is known about the link between ROR2 and the G2/M phase cell cycle in GC. Here, the findings of our study indicate that ROR2, after transcribed expression by Twist1, activates the PI3K/AKT/mTOR/S6K signal transduction pathway, thus leading to the acceleration of the G2/M phase and subsequent promotion of cell proliferation in GC. Furthermore, the functional link among ROR2, Twist1, and G2/M phase of cell cycle was also confirmed in mouse xenograft tissues and human tissues. ROR2 expression was correlated with Twist expression and lower survival in vivo. Notably, our suggestion is that focusing on ROR2 as a potential therapeutic approach could show potential for the management of GC.

Plastic production has experienced a significant increase in the last sixty years due to its cost-efficiency and adaptable characteristics, leading to the extensive use of additives to improve its performance and longevity. Due to the high demand for plastic, plastic waste production has increased, contaminating the environment and living beings by leaching additives, among other substances. Pyrolysis stands out among recycling techniques because it can handle mixed polymer waste feedstock. However, understanding the pyrolyzates distribution of additives is fundamental to assessing pyrolysis process of plastic waste. This study investigated the pyrolysis product distributions of two commonly used antioxidants, namely, Irgafos 168 and zinc stearate (ZnSt), using one-dimensional gas chromatography equipped with a quadruple mass spectrometer (GC-MS) and two-dimensional gas chromatography coupled to flame ionization detector and time-of-flight mass spectrometer (GC×GC-FID/TOF-MS). While GC separation technique provided limited information on product distribution, GC×GC offered enhanced resolution and identification of the decomposition products. In the pyrolysis of Irgafos 168 at 550 °C, GC identified 18 products, while GC×GC identified 198 products, representing an increase of approximately 11-fold. Similarly, for ZnSt, GC identified 67 products, while GC×GC identified 434 products, representing a 6-fold increase. GC×GC identified decomposition products from 15 different chemical classes for Irgafos 168 and 16 chemical classes for ZnSt, compared to 4 and 11 chemical classes identified by GC, respectively. Phenols and their derivatives were the major chemical class in the decomposition products of Irgafos 168 with a yield of 9.51 wt.%. In contrast, olefinic products were the dominant ones for ZnSt, with a yield of 9.73 wt.%. The major decomposition product of Irgafos 168 and ZnSt was 2‑tert‑butyl‑methylphenol (C11H16O) and C6 olefin (C6H12) with yields of 3.88 wt.%, and 1.13 wt.%, respectively. Utilizing the GC×GC separation method improved the ability to identify decomposition products, which can ultimately lead to a better understanding of antioxidant degradation that occurs during the pyrolysis process. GC×GC also provided thorough characterization of minor and co-eluted products along with major antioxidant degradation products. Additionally, the decomposition product distribution of Irgafos 168 and ZnSt was also compared with the primary antioxidants, Irganox 1010, Irganox 1076, and BHT, studied in part 1. The analysis indicated that the olefinic chemical class was the predominant one in Irganox 1010, Irganox 1076, and ZnSt, while ketones were the major chemical class in the decomposition of BHT and phenolics had the highest yield in Irgafos 168.

Plastics incorporate diverse additives, including primary antioxidants with a typical amount between 0.05 to 3 wt.%, to enhance plastics functionality and durability, preventing their oxidation and maintaining their mechanical properties. While these antioxidants offer substantial benefits, their degradation can significantly impact plastic pyrolysis by changing the pyrolysis oil product distribution. Understanding the intricate distribution of decomposition products resulting from pyrolysis is essential yet often overlooked. This study delved into the analysis of the decomposition of common primary antioxidants, namely, Irganox 1010, Irganox 1076, and butylated hydroxytoluene (BHT), utilizing both one-dimensional gas chromatography coupled with a quadruple mass spectrometer (GC-MS) and two-dimensional gas chromatography equipped with flame ionization detector and time-of-flight mass spectrometer (GC×GC-FID/TOF-MS). This study showed that GC×GC-FID/TOF-MS provided a more detailed characterization of the pyrolysis product distribution of primary antioxidants used in plastics in comparison to GC-MS. For each of the antioxidants, using the GC×GC-FID/TOF-MS analytical approach enhanced the identification of degradation products at least fivefold. Furthermore, GC×GC-FID/TOF-MS identified products of more chemical classes than GC-MS. For instance, compounds from 14 chemical classes were identified from GC×GC-FID/TOF-MS in the pyrolysis of Irganox 1010, whereas only 9 chemical classes were identified in GC-MS. Olefins were the major chemical class for both Irganox 1010 and Irganox 1076 in the decomposition process, accounting for 23.25 wt.% and 20.76 wt.%, respectively. Ketones were the major chemical class in the case of BHT, having a 6.68 wt.% yield. This research enhanced the understanding of the decomposition of primary antioxidant and their product distribution during pyrolysis and shed light on the potential necessity for using two-dimensional gas chromatography.

Although an association exists between the timing of immune checkpoint inhibitor (ICI) administration and therapeutic efficacy in several types of cancer, to the best of our knowledge, no reports exist regarding this relationship in gastric cancer (GC). The present study aimed to evaluate the optimal timing of ICI (nivolumab) administration in patients with advanced GC. A total of 58 consecutive patients with advanced GC who received nivolumab monotherapy after ≥2 chemotherapy regimens were retrospectively evaluated. These patients were divided into two groups according to the median time of nivolumab administration: i) Early-timing and (ii) late-timing groups, and the efficacy was assessed in both groups. The early-timing group had significantly longer overall survival (OS) than the late-timing group [median OS 8.2 months; 95% confidence interval (CI), 4.2-12.9 vs. median OS 5.4 months; 95% CI, 3.6-6.1]. Moreover, patients in the early-timing group had significantly longer progression-free survival (PFS) than those in the late-timing group (median PFS 2.6 months; 95% CI, 1.3-3.9 months vs. median PFS 1.6 months; 95% CI, 0.9-2.1 months). Furthermore, univariate analysis showed that early timing, immune-related adverse events and nonsteroidal anti-inflammatory drug administration were associated with longer OS and PFS. Cutoff Finder analysis revealed that the optimal timing of nivolumab administration for achieving better outcomes was before 12:06 p.m. Nivolumab administration in the morning, especially before 12:06 p.m., had a better clinical impact on patients with advanced GC.